David Robinson
Family · Vestal, NYNPI 1225363450
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 202 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 17.2% — the pattern of someone who eats at a lot of different presentations. Among family clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 202 payments — averaging $17.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$605
- AstraZeneca$414
- Optinose US, Inc.$295
- CSL Behring$266
- Amgen$265
- Novartis$264
- plus $1K from 16 others
What the payments were for
- Food & beverage$3,510100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 40 | $605 |
| AstraZeneca | 25 | $414 |
| Optinose US, Inc. | 19 | $295 |
| CSL Behring | 14 | $266 |
| Amgen | 13 | $265 |
| Novartis | 16 | $264 |
| Sanofi | 10 | $235 |
| Takeda Pharmaceuticals U.S.A., Inc. | 13 | $223 |
| Teva Pharmaceuticals USA, Inc. | 12 | $198 |
| Regeneron Healthcare Solutions, Inc. | 6 | $111 |
| Blueprint Medicines Corporation | 6 | $101 |
| Pfizer | 5 | $91 |
| ARS Pharmaceuticals Operations, Inc. | 4 | $86 |
| Octapharma USA, Inc. | 4 | $82 |
| Kaleo, Inc. | 4 | $64 |
| Boehringer Ingelheim | 3 | $61 |
| Merck | 2 | $42 |
| Pharming Healthcare, Inc. | 2 | $37 |
| Lilly USA, LLC | 1 | $22 |
| Ionis Pharmaceuticals, Inc. | 1 | $21 |
| Paratek Pharmaceuticals, Inc. | 1 | $15 |
| Alk-abello, Inc | 1 | $12 |
How this compares
$3,510 in reported general payments places this provider in the 90th percentile of 8,883 family providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trihexyphenidyl Hcl | 22 | $169 |
Paid to pharmacies, not to this prescriber.
Other family in Vestal
- Christina NalboneNew York$197K
- Casey GrilloNew York$191K
- Suzanne WilsonIthaca$179K
- Jonathan LesuerSyracuse$172K
- Sheri HillNorth Syracuse$165K
- Cathrine CurtinBronxville$155K
- Mary Sullivan-WhalenNew York$137K
- Sarah AljahmiRockville Centre$87K
- John de OcaStaten Island$86K
- Fara StrickerGlen Oaks$85K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.